Pilot Study of Lenalidomide and Dexamethasone in Combination With MEDI-551 in Previously Untreated Multiple Myeloma.
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Inebilizumab (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Pharmacodynamics; Therapeutic Use
- 27 Sep 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 27 Sep 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 12 Oct 2016 Planned End Date changed from 1 Aug 2016 to 1 Jun 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History